2020
DOI: 10.1002/cncr.32971
|View full text |Cite
|
Sign up to set email alerts
|

Induction chemotherapy is the best timekeeper in nasopharyngeal carcinoma

Abstract: NPC‐0501 has shown that induction chemotherapy provides a survival benefit for patients with locoregionally advanced nasopharyngeal carcinoma and has added evidence to current knowledge. In the intensity‐modulated radiotherapy era, neoadjuvant chemotherapy should be considered at least for patients with high‐risk disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Simultaneous chemotherapy can enhance the antitumor effect and reduce the metastasis and recurrence rates. [ 2 , 3 ] However, radiotherapy and chemotherapy have limitations. [ 4 ] The side effects caused by this treatment, such as dry mouth, mucosal injury, and nerve injury, result in significant levels of pain and lead to a decline in quality of life.…”
Section: Introductionmentioning
confidence: 99%
“…Simultaneous chemotherapy can enhance the antitumor effect and reduce the metastasis and recurrence rates. [ 2 , 3 ] However, radiotherapy and chemotherapy have limitations. [ 4 ] The side effects caused by this treatment, such as dry mouth, mucosal injury, and nerve injury, result in significant levels of pain and lead to a decline in quality of life.…”
Section: Introductionmentioning
confidence: 99%